Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Schwann cells: a new player in the tumor microenvironment.

Bunimovich YL, Keskinov AA, Shurin GV, Shurin MR.

Cancer Immunol Immunother. 2017 Aug;66(8):959-968. doi: 10.1007/s00262-016-1929-z. Epub 2016 Nov 24. Review.

2.

The Neurobiology of Cancer Pain.

Schmidt BL.

J Oral Maxillofac Surg. 2015 Dec;73(12 Suppl):S132-5. doi: 10.1016/j.joms.2015.04.045. Review.

3.

A lipid gate for the peripheral control of pain.

Piomelli D, Hohmann AG, Seybold V, Hammock BD.

J Neurosci. 2014 Nov 12;34(46):15184-91. doi: 10.1523/JNEUROSCI.3475-14.2014. Review.

4.

JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy.

Khasabova IA, Yao X, Paz J, Lewandowski CT, Lindberg AE, Coicou L, Burlakova N, Simone DA, Seybold VS.

Pharmacol Res. 2014 Dec;90:67-75. doi: 10.1016/j.phrs.2014.09.008. Epub 2014 Oct 7.

5.

CXCL12 in astrocytes contributes to bone cancer pain through CXCR4-mediated neuronal sensitization and glial activation in rat spinal cord.

Shen W, Hu XM, Liu YN, Han Y, Chen LP, Wang CC, Song C.

J Neuroinflammation. 2014 Apr 16;11:75. doi: 10.1186/1742-2094-11-75.

6.

The neurobiology of cancer pain.

Schmidt BL.

Neuroscientist. 2014 Oct;20(5):546-62. doi: 10.1177/1073858414525828. Epub 2014 Mar 24. Review.

7.

Resiniferatoxin (RTX) causes a uniquely protracted musculoskeletal hyperalgesia in mice by activation of TRPV1 receptors.

Abdelhamid RE, Kovács KJ, Honda CN, Nunez MG, Larson AA.

J Pain. 2013 Dec;14(12):1629-41. doi: 10.1016/j.jpain.2013.07.021. Epub 2013 Nov 1.

8.

The non-selective cannabinoid receptor agonist WIN 55,212-2 attenuates responses of C-fiber nociceptors in a murine model of cancer pain.

Uhelski ML, Cain DM, Harding-Rose C, Simone DA.

Neuroscience. 2013 Sep 5;247:84-94. doi: 10.1016/j.neuroscience.2013.05.003. Epub 2013 May 11.

9.

Increased anandamide uptake by sensory neurons contributes to hyperalgesia in a model of cancer pain.

Khasabova IA, Holman M, Morse T, Burlakova N, Coicou L, Harding-Rose C, Simone DA, Seybold VS.

Neurobiol Dis. 2013 Oct;58:19-28. doi: 10.1016/j.nbd.2013.04.018. Epub 2013 May 2.

10.

Peroxisome proliferator-activated receptor α mediates acute effects of palmitoylethanolamide on sensory neurons.

Khasabova IA, Xiong Y, Coicou LG, Piomelli D, Seybold V.

J Neurosci. 2012 Sep 12;32(37):12735-43. doi: 10.1523/JNEUROSCI.0130-12.2012.

11.

Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy.

Khasabova IA, Khasabov S, Paz J, Harding-Rose C, Simone DA, Seybold VS.

J Neurosci. 2012 May 16;32(20):7091-101. doi: 10.1523/JNEUROSCI.0403-12.2012.

12.

CB1 and CB2 receptor agonists promote analgesia through synergy in a murine model of tumor pain.

Khasabova IA, Gielissen J, Chandiramani A, Harding-Rose C, Odeh DA, Simone DA, Seybold VS.

Behav Pharmacol. 2011 Sep;22(5-6):607-16. doi: 10.1097/FBP.0b013e3283474a6d.

13.

Painful pathways induced by TLR stimulation of dorsal root ganglion neurons.

Qi J, Buzas K, Fan H, Cohen JI, Wang K, Mont E, Klinman D, Oppenheim JJ, Howard OM.

J Immunol. 2011 Jun 1;186(11):6417-26. doi: 10.4049/jimmunol.1001241. Epub 2011 Apr 22.

14.

Increasing 2-arachidonoyl glycerol signaling in the periphery attenuates mechanical hyperalgesia in a model of bone cancer pain.

Khasabova IA, Chandiramani A, Harding-Rose C, Simone DA, Seybold VS.

Pharmacol Res. 2011 Jul;64(1):60-7. doi: 10.1016/j.phrs.2011.03.007. Epub 2011 Apr 2.

15.

Hematopoietic colony-stimulating factors: new players in tumor-nerve interactions.

Stösser S, Schweizerhof M, Kuner R.

J Mol Med (Berl). 2011 Apr;89(4):321-9. doi: 10.1007/s00109-010-0697-z. Epub 2010 Nov 16. Review.

16.

Cytokine and chemokine regulation of sensory neuron function.

Miller RJ, Jung H, Bhangoo SK, White FA.

Handb Exp Pharmacol. 2009;(194):417-49. doi: 10.1007/978-3-540-79090-7_12. Review.

17.

Secretion of MCP-1 and other paracrine factors in a novel tumor-bone coculture model.

Schiller KR, Zillhardt MR, Alley J, Borjesson DL, Beitz AJ, Mauro LJ.

BMC Cancer. 2009 Feb 3;9:45. doi: 10.1186/1471-2407-9-45.

18.

P2X receptors in sensory neurons co-cultured with cancer cells exhibit a decrease in opioid sensitivity.

Chizhmakov I, Mamenko N, Volkova T, Khasabova I, Simone DA, Krishtal O.

Eur J Neurosci. 2009 Jan;29(1):76-86. doi: 10.1111/j.1460-9568.2008.06556.x. Epub 2008 Dec 11.

19.

A decrease in anandamide signaling contributes to the maintenance of cutaneous mechanical hyperalgesia in a model of bone cancer pain.

Khasabova IA, Khasabov SG, Harding-Rose C, Coicou LG, Seybold BA, Lindberg AE, Steevens CD, Simone DA, Seybold VS.

J Neurosci. 2008 Oct 29;28(44):11141-52. doi: 10.1523/JNEUROSCI.2847-08.2008.

20.

Chemokines and the pathophysiology of neuropathic pain.

White FA, Jung H, Miller RJ.

Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20151-8. Epub 2007 Dec 14. Review.

Supplemental Content

Support Center